The 2020 Advancing Ethical Research Conference (AER20) will be presented virtually as a series of shorter, half-day online events spread out over three weeks in December:
Week 1: December 1-2 Week 2: December 8-9 Week 3: December 15-16
Click on "Agenda" in the left hand navigation to view weekly content. You can sort the agenda by week, track, target audience, and more.
Attendees can register for one or more weeks (you only receive the content for the weeks you are registered), and have the option to add shorter half-day workshops. AER20 will still provide the essential content and networking opportunities you expect from PRIM&R's in-person conferences, in a format that's more manageable for online viewing and busy work schedules.
Conference content will be streamed live each from 10:00 AM to 2:15 PM ET each day (all content will be available on demand for later viewing). In the afternoon, attendees can choose to participate in additional networking activities with their peers, visit the virtual exhibit hall and poster gallery, attend Federal Agency Office Hours, and more, or attend in-depth workshops (these are an additional fee; see information on workshops below).
Each afternoon of the conference, from 2:30 to 5:30 PM ET, we will host in-depth workshops that will provide a deeper dive into specific topics (on December 1, we’ll host two concurrent programs). These courses are an additional fee (information on fees can be found here). Information on these courses, including which are CIP accredited, can be found here.
Thank you to this year's conference planning committees. If you're interested in serving on a conference planning committee in the future, contact us.
Core Conference Planning Committee
Co-Chairs: Albert J. Allen, MD, PhD, Senior Medical Fellow, Pediatric Capabilities, Global Medical Policy Strategy and Operations, Medicines Development Unit, Eli Lilly and Company Elizabeth A. Buchanan, PhD, Director, Office of Research Support Services; Staff Senior Research Scientist, Marshfield Clinic Research Institute
Members: Melissa Abraham, MS, PhD, Director, Research Ethics Consultation Unit, Division of Clinical Research, Massachusetts General Hospital/Harvard Medical School Center for Bioethics/Ariadne Labs John R. Baumann, PhD, Associate Vice President for Research Compliance, Office of Research Compliance, Indiana University Brenda L. Curtis, PhD, MSPH, Clinical Investigator; Chief, Technology and Translational Science Section, NIH Neal W. Dickert Jr., MD, PhD, Assistant Professor, Division of Cardiology, School of Medicine; Assistant Professor, Department of Epidemiology, Rollins School of Public Health, Emory University Nancy M. P. King, JD, Professor of Social Sciences & Health Policy, Wake Forest School of Medicine Ivor A. Pritchard, PhD, Senior Advisor to the Director, OHRP Benjamin Silverman, MD, IRB Chair, Partners Human Research Committee, Partners Healthcare System Julie Slayton, JD, Director, Office for the Protection of Research Subjects; Professor of Clinical Education, University of Southern California Sarah White, MPH, Executive Director, Multi-Regional Clinical Trials Center at Brigham and Women's Hospital and Harvard
Co-Chairs: Michelle M. Feige, MSW, LCSW-C, Executive Vice President, AAHRPP, Inc. Megan Kasimatis Singleton, CIP, JD, MBE, Assistant Dean, Human Research Protection; Director, HRPP, Johns Hopkins University School of Medicine
Members: Amy Ben Arieh, Director of Research Compliance, the Fenway Institute Quincy J. Byrdsong, EdD, CIM, CIP, CCRP, Vice Provost for Health Affairs; Associate Professor for Bioscience and Ethics, Lipscomb University Karla Childers, MSJ, Senior Director, Strategic Projects, Office of the Chief Medical Officer, Johnson & Johnson Nichelle Cobb, PhD, Director, Health Sciences IRBs Office, University of Wisconsin-Madison Janet C. Donnelly, RAC, CIP, Policy Analyst, Office of Good Clinical Practice, Food and Drug Administration Andrew Hedrick, CIP, MPA, Senior IRB Protocol Analyst, The Ohio State University Kate Gallin Heffernan, JD, Partner; Chair, Academic and Clinical Research Group, Verrill Dana LLP John Horigan, CIP, MA, Director of IRB and Protocol Compliance, All of Us Research Program, NIH R. Peter Iafrate, PharmD, IRB-01 Chair; Assistant Director, Research Programs and Services; IRB Chairman, University of Florida Yvonne Lau, MBBS, MBHL, PhD, Director, Division of Education and Development, OHRP Andrea McDowell, IRB Administrator, Seattle University Sara Meeder, CIP, Director, Institutional Review Board, Maimonides Medical Center Kenia Viamonte, Associate Director, Compliance and IRB Affairs, University of Miami
Poster Abstract Subcommittee
Co-Chairs: Emily E. Anderson, PhD, MPH, Assistant Professor of Bioethics, Loyola University Chicago Warren Capell, MD, Clinician-Scientist CPC Clinical Research; Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado at Denver
Members: Kristina C. Borror, PhD, Director of Policy and Education, Office of Research Oversight, Veterans Health Administration Stephanie Solomon Cargill, PhD, Assistant Professor, Center for Health Care Ethics, Saint Louis University Stacy Chandna, MS, CIP, Director, Human Research Protection Program, Connecticut Children’s Medical Center Liza Dawson, PhD, Chief of Bioethics, Chair of IRB, Walter Reed Army Institute of Research Sarah Fowler-Dixon, PhD, CIP, Education Specialist, Clinical Research Management and Research Ethics; Instructor, Washington University in St. Louis Ran Goldman, MD, Professor, Department of Pediatrics, University of British Columbia, BC Children's Hospital Jan Hewett, BSN, JD, Regulatory Counsel, Policy, Office of Scientific Investigations, Center for Drug Evaluation and Research, FDA Le’Quan Jackson, CIP, IRB Administrator, Kaiser Permanente Northern California Sana Khoury-Shakour, PhD, Director, Office of Research Compliance Review, University of Michigan Hallie Kassan, MS, CIP, Director, Office of the HRPP, Northwell Health Michael Linke, PhD, CIP, IRB Chair; Associate Professor, University of Cincinnati College of Medicine; Health Science Officer, Cincinnati VA Medical Center; Chair, Central IRB, StrokeNet, NIH Hiromi Martorano, PhD, CIP, IRB Program Manager, SCL Health Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WIRB-Copernicus Group Casey Mumaw, CIP, MA, Assistant Director, IU Human Subjects Office, Office of Research Compliance, Indiana University Stuart Nicholls, PhD, Senior Clinical Research Associate, Clinical Epidemiology Program, Ottawa Hospital Research Institute Kelley O’Donoghue, MPH, CIP, Associate Vice President for Human Subject Protection; University of Rochester Nancy A. Olson, JD, Consultant in Human Research Protections Brenda Ruotolo, CIP, Executive Director, Human Research Protection Office, Columbia University Cheryl A, Savini, CIP, Principal, COO, HRP Consulting Group, Inc. Kimberly Serpico, MEd, CIP, EdD, Candidate, Assistant Director of IRB Operations, Harvard School of Public Health Holly A. Taylor, PhD, MPH, Associate Professor, Berman Institute of Bioethics, Johns Hopkins Bloomberg School of Public Health